The product is a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years.

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

The Federal Circuit upheld a ruling that Moderna's COVID-19 vaccine does not infringe Alnylam's mRNA patents related to the SM-102 lipid used in Spikevax.

Rep. Marjorie Taylor Greene is sounding the alarm about a provision in the One Big Beautiful Bill Act that would restrict states from regulating artificial intelligence for a decade.

Higher first-trimester maternal BMIs were associated with increased risk of serious infections in children, especially when ...

Two measles patients this week, a child from New Mexico and adult from Minnesota, contracted the virus on domestic flights.

Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving ...